BioNTech SE (BNTX)

99.60 +1.08 (+1.10%) USD  |  NASDAQ  |  Sep 28, 14:16
More

BioNTech Cash from Operations (Annual) : 514.63M for Dec. 31, 2025

Cash from Operations (Annual) Chart

View Cash from Operations (Annual) for BNTX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Operations (Annual) Chart
Start Trial

Historical Cash from Operations (Annual) Data

View and export this data back to 2017. Start Trial.
Date Value
December 31, 2025 514.63M
December 31, 2024 224.67M
December 31, 2023 5.807B
December 31, 2022 14.27B
December 31, 2021 1.052B
Date Value
December 31, 2020 -15.36M
December 31, 2019 -222.21M
December 31, 2018 -68.64M
December 31, 2017 -59.29M

Cash From Operations Definition

Represents the net cash flow from the company's business operations.

Read full definition.

Cash from Operations (Annual) Range, Past 5 Years

View Cash from Operations (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Operations (Annual) Benchmarks

View Cash from Operations (Annual) Benchmarks
Start Trial
Moderna, Inc. -1.873B
Biodexa Pharmaceuticals Plc -7.268M
NuCana Plc -9.377M
Mereo BioPharma Group Plc -31.04M
MediGene AG --